This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Masao Hirakata: Innovator in Pharmaceutical Chemistry
Introduction
Masao Hirakata is a prominent inventor based in Fujisawa, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address critical health issues.
Latest Patents
Hirakata holds a patent for a heterocyclic compound, specifically N-((3S,4R)-1-((8-chloroquinoxalin-6-yl)carbonyl)-3-(4-fluorophenyl)piperidin-4-yl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole-3-carboxamide. This compound has potential applications in the treatment or prevention of SPT-related diseases, including congenital diseases associated with the storage of sphingolipids, such as cancer and Niemann-Pick disease.
Career Highlights
Masao Hirakata is affiliated with Takeda Pharmaceutical Company Limited, where he continues to innovate and contribute to the advancement of medical science. His work focuses on developing new therapeutic options that can significantly improve patient outcomes.
Collaborations
Hirakata collaborates with notable colleagues, including Katsunori Nagai and Takuto Kojima. These partnerships enhance the research and development efforts within the pharmaceutical industry.
Conclusion
Masao Hirakata's contributions to pharmaceutical chemistry and his innovative patent demonstrate his commitment to addressing significant health challenges. His work continues to impact the field positively, paving the way for future advancements in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile